Results
The SAD but not the normal group showed a phase advance of melatonin rhythms in response to phototherapy There was an association between phase position and phase shift in the SAD but not in the normal group.
Conclusions
There may be instability ofcircadian rhythms in SAD mediated by a high-amplitude phase response curve, rather than a fixed phase abnormality as had been previously suggested.This instability may be secondary to impaired serotoninergic function in the afferent pathways to the suprachiasmatic nuclei.
The aetiology of seasonal affective disorder (SAD; Rosenthal et al, 1984) would appear at first sight to be more amenable to investigation than that of other forms of depression. The periodic occurrence of depression and its association with winter conditions, suggests a biological basis in circadian or circannual physiology (Thompson, 1985) . The therapeutic response to a novel non-pharmacological treatmentphototherapy -has also provided a rich source of hypotheses based on circadian mechanisms (Rosenthal & Wehr, 1992) . The prominence of the atypical vegetative symptoms of depression and the therapeutic response to d-fenfluramine (O'Rourke et al, 1987) suggests a relationship to serotoninergic mechanisms. Despite these theoretical advantages the field remains controversial, and few studies of the aetiology of SAD or the mechanism of action of phototherapy have been replicated. Two main theories have been proposed. The first (Lewy et al, 1987) proposes that there are phase-delayed circadian rhythms in SAD which are corrected by phototherapy. The second (Rosenthal et al, 1984) proposes that there are impaired serotoninergic mechanisms in the winter which are corrected by serotonin reuptake inhibitors such as fluoxetine (Lam et a/, 1995) , and by d-fenfluramine (O'Rourke et a/, 1987) , and made worse by rapid tryptophan depletion (Lam et al, 1996) . A third hypothesis, also related to circadian mechanisms, proposes that the amplitude of circadian rhythms is impaired in SAD (Czeisler et al, 1987) .
The sensitivity of melatonin to suppression by light, first shown by Lewy et a1 (1980) , has been found to be intensitydependent (Bojkowski et al, 1987; McIntyre et al, 1989a ), time-dependent (McIntyre et al, 1989b , greater in bipolar disorder than in normal controls (Lewy et al, 1981 (Lewy et al, , 1985 , but no greater in unipolar depressed patients (Cummings et al, 1989) . In SAD patients have been found to be supersensitive to light in winter compared with control subjects, and also compared with themselves when well in the summer (Thompson et a/, 1990) . Light sensitivity is relevant to the circadian hypothesis of SAD because phase position is determined by: (a) environmental zeitgeber strength (e.g. light); (b) sensitivity of the organism to the zeitgeber; (c) the intrinsic period (tau); and (d) the amplitude of the endogenous circadian rhythm.
The seasonal change in light sensitivity led us to propose that the circadian abnormality in SAD may be an instability of rhythms in winter. This hypothesis led to two predictions. The first was that morning phototherapy would phase-advance circadian rhythms of melatonin in SAD but not in normal control subjects. The second was that increasing serotoninergic activity by a therapeutic dose of a selective serotonin reuptake inhibitor would reduce light sensitivity in SAD patients but not in control subjects. We now report the results of the first of these studies. The second will be reported separately.
METHOD Subjects
Twelve SAD subjects (Table 1 ) were recruited from the Southampton Mood Disorders clinic, which specialises in SAD and has a group which has been followed prospectively for a number of years to ensure their periodicity. All fulfilled DSM-111-R for major depressive disorder with seasonal pattern (American Psychiatric Association, 1987) . All gave informed consent to the study and had a score on the 29-item Hamilton Rating Scale for Depression using the interview guide (SIGH-SAD; Williams et al, 1987) of at least 20. All patients were drug-free and none had used light treatment within two weeks of the study.
Each patient was individually matched for age, gender and month of testing with a normal control subject drawn from a pool of volunteers on the hospital staff. N o control subject had mood disorder in their personal or family history, and none was taking medication or had significant physical illness.
All subjects received a full physical examination including fundoscopy.
Procedures
All testing took place in the winter months in a light-controlled clinical investigation unit. Results were obtained using a standard test procedure as follows. Each subject underwent the testing procedures described above before and after treatment with phototherapy. Night 1 results (all but light sensitivity) were complete for all 12 SAD patients and controls before and after treatment. Eleven SAD patients completed all procedures, but night 2 results were unavailable either before or after treatment for three normal controls. One of these was the matched pair for the unavailable SAD patient. Thus the light sensitivity results comparing SAD before and after phototherapy are based on Ii subjects and nine normal controls. The comparison of the change in light sensitivity between SAD and normal control subjects is based on nine matched pairs.
Phototherapy treatment
The SAD patients were treated with either 2500 lux morning phototherapy from 07.00 to 09.00 hours for one week, or 10 000 lax from 07.00 to 09.00 hours for two weeks. The protocol was altered after the first eight subjects (one of whom was excluded from light sensitivity analysis) because of new experimental information indicating greater clinical effects of the higher exposures (Terman et a!, 1989) . The mean light intensity for the I 1 completed SAD patients was 5227 lux (seven at 2500 lux, four at 10 000 lux) over 1.36 weeks (seven at one week, four at two weeks), and the normal control subjects were matched on this van able. The mean light intensity for the nine SADsubjects and matched controls who gave
The subject was admitted for two consecutive nights and remained during the entire time in environmental light of less than SO lux, except during the second night's light sensitivity test (see below). On admission the clinical diagnosis was confirmed using the Structured Clinical Interview for DSMâ€"IIIâ€"R and the current severity was rated using the SIGH-SAD.
On each night a cannula was inserted into an antecubitalfossavein at 17.00 hours and connected to a three-way tap. The line was kept patent with 20 units/mI hepar inised saline at 4 ml per hour. Blood samples were collected from 18.00 to 22.00 hours at half-hourly intervals, then at 23.00 and 24.00 hours, then at half-hourly intervals from 24.00 to 03.00, and hourly intervals from 03.00 to 07.00 hours when the cannula was removed.
On the second night sampling occurred at 22.00, 23.00 and 24.00 hours, and then half-hourly to 03.00 when the cannula was withdrawn.
From 00.30 to 01.30 on the second night the subject was exposed to 2000 lux full spectrum artificial light. The experi menter remained with the subject during this time to ensure compliance with the exposure.
All blood samples were immediately centrifuged at 4000 r.p.m. for seven minutes, and the plasma decanted and stored at â€"¿ 20Â°C. Melatonin was subse quently assayed by the radioimmunoassay technique of Fraser eta! (1983) using tritiated melatonin and a melatonin-specific anti serum. The lower limits of sensitivity were 4â€"6.25pg/mI. The coefficients of variation between assays were 6.3% at 21.9 pglml, 8.0% at 100.9 pg/ml, and 5.9% at 202.4 pg/ ml. The variability within assays was 7.95% at 23.7 pg/ml, 6.6% at 132.9 pg/ml, and 7.7% at 182.6 pg/ml.
Measures derived from sampling
From the above samples the following measures could be derived for each subject at each time of testing (Fig. 1) .
(1) Dim Light Melatonin Onset (DLMO) on the first night: the time that the plasma melatonin first rose above 10.0 pg/mI and remained so for the next three consecutive samples. This has been used as a marker of circadian position.
(2) Time of the actual (not fitted) maximum melatonin value (Tmax)Oflthe first night. (5) Light sensitivity was calculated as described by Thompson et a! (1990) . Each melatonin value between 10.00 and 03.00 hours on each night was expressed as a percentage of that night's (lights on) value at 00.30 evaluable data for light sensitivity was 5833 lux (five at 2500 lux and four at 10 000 lux) over 1.44 weeks (five at one week, four at two weeks).
RESULTS
In the SAD patients, phototherapy modestly but significantly reduced depressive symptoms (P=0.044, paired t-test, two-tailed; see Table 2 ). The mean plasma melatonin levels at each sampling point are shown in Fig. 3 for normal control subjects. The results for the five key variables are shown in Table 2 . There were no significant differences between the groups in any circadian variable before treatment. In the SAD group the DLMO advanced significantly during treatment (Wilcoxon P=0.03). In the normal control group there was a much smaller non-significant phase advance.
There was a trend towards phase advance in the T,,, of the SAD group (Wilcoxon P=0.08) and individual sample times revealed significant increases in plasma melatonin at 22.00 hours (Wilcoxon P=0.034), and reductions at 06.00 hours (Wilcoxon P=0.012) and 07.00 hours (Wilcoxon P=0.04), consistent with evidence presented above for a phase advance (Fig. 2) . No differences in individual sampling times were apparent at any time in the control group (Fig 3) .
There was no difference between SAD and control groups in the area under the curve, nor was there a significant change with treatment in either group. Peak melatonin values similarly did not vary between groups, nor did they change with treatment. There was no significant change in light sensitivity with treatment in either group. Circadian time was estimated from the time of peak melatonin, which is usually within one hour of the temperature minimum, the usual circadian reference point. The circadian timing of light exposure then varied between individuals depending upon their phase relationship at the start of the study. In the SAD group there was a correlation between phase shift and circadian timing (r=-0.74, P=0.006), while there was no correlation in the control group (r= -0.48, P=0.12).
Although the change in the DLMO timing was confined to the SAD group, there was no significant correlation between the size of this effect and the percentage phototherapy to be given clinically at this time.
LIM ITATIONS

DISCUSSION
U The study was not carried out in a constant routine paradigm.
. The subjectswere not standardised to a pre-treatment phaseposition.
. Two intensities of lightwere usedfor treatment.
Phototherapy produced a significant reduc tion in depression severity, but no conclu sions can be drawn about its effectiveness as the study was not placebo-controlled. The size of the effect was less than had been anticipated, possibly because patients were recruited early in their episode such that failure of the episode to develop might be counted as a partial therapeutic success. Another cause may have been the relatively low light levels and duration used in the earlier parts of the study.
The study was carried out in carefully controlled lighting conditions to prevent masking of the change in melatonin secre tion, but subjects were not kept in a constant regime with respect to activity and food as advocated by other workers (Wirz-Justice et a!, 1994) . Although the constant regime may be necessary to elucidate subtle changes in circadian rhythms, there is also a place for studies such as this in more clinically meaningful conditions. Despite these caveats, these results provide further evidence for circadian rhythm abnormalities in SAD which are not present in matched normal control subjects. What implications do they have for the three principal theories of SAD aetiology? Firstly, we have found no evidence that SAD is caused by reduced amplitude of circadian rhythms (Czeisler et a!, 1987) .
In the second hypothesis, Lewy et a! (1987) predicted that patients with winter depression would have phase-delayed circadian rhythms. Efforts at replication have, however, failed on a number of occasions (e.g. Winton et a!, 1989) . This study has also failed to find a significant pre-treatment phase delay in the SAD compared with the normal group, although there was a weak trend in this direction (SAD DLMO delayed by one hour compared with controls). The main finding of our phototherapy study is that the SAD group's phase relationship is unstable, showing an abnormal degree of phase advance during treatment with morning light. This instability, rather than a static phase change, appears to be a more characteristic abnormality of SAD. Phase delay alone is an insufficient explanation of the findings, because group differences at baseline were not found, and the responses to the interven tion were significant only in the SAD group.
A further prediction was that light sensitivity might be reduced by phase advance, suggesting that the increased light sensitivity in SAD patients in winter might have been secondary to phase delay. This was not confirmed. One explanation might be that light sensitivity increases during the dark phase, and that after phase advance the light would therefore fall on a more sensitive portion of the curve, thus hiding any real decrease in light sensitivity. However, there was no correlation between DLMO and light sensitivity in either SAD (P=0.88) or control (P=0.74) groups, so it is unlikely that this mechanism was significant. We must conclude from these data that there is no relationship between light sensitivity and phase position, and that therefore phase delay probably did not account for the previously observed increase in light sensi tivity in winter.
The phase shifting effects of photo therapy showed, as expected, a strong relationship to circadian time, particularly in the SAD group. However, we only have data relating to the advance portion of the light phase response curve (PRC). In addi tion, the study was not designed specifically to test the amplitude of the PRC. In consequence the data points are not distrib uted evenly across the important time periods, and the cases given light at each circadian time are self-selected (i.e. it depended on their phase position). Two different doses of light were used in each group and it was not possible to control the distribution of those who received the high dose. However, the 10 000 lux patients had phase advances which were as likely to lie above the mean as below it, so the intensity may not have been critical.
CONCLUSIONS
We have shown evidence of phase advance after phototherapy in SAD patients but not in controls, suggesting an instability of circadian rhythms which may be related to a high amplitude PRC, a new hypothesis of the aetiology of SAD. This supplements evidence from studies of seasonal change in light sensitivity (Thompson et a!, I 990). This instability is interpreted as being due to a change in the phase response curve, possibly mediated by serotonin.
